Eqis Capital Management, Inc. Orasure Technologies Inc Transaction History

Eqis Capital Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$4.88 - $7.39 $7,925 - $12,001	1,624 Added 7.64%	22,890 $114,000
Q1 2023 May 15, 2023	BUY	$4.66 - $6.52 $99,099 - $138,654	21,266 New	21,266 $128,000
Q2 2022 Aug 08, 2022	SELL	$2.71 - $7.12 $61,324 - $161,118	-22,629 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.62 - $9.33 $182,791 - $257,619	-27,612 Reduced 54.96%	22,629 $153,000
Q4 2021 Feb 14, 2022	SELL	$8.3 - $11.29 $2,016 - $2,743	-243 Reduced 0.48%	50,241 $437,000
Q3 2021 Nov 12, 2021	BUY	$9.73 - $13.38 $232,060 - $319,113	23,850 Added 89.55%	50,484 $571,000
Q2 2021 Aug 12, 2021	SELL	$9.02 - $11.68 $5,565 - $7,206	-617 Reduced 2.26%	26,634 $270,000
Q1 2021 May 14, 2021	BUY	$9.53 - $15.42 $259,702 - $420,210	27,251 New	27,251 $318,000

202

65.5M

2.2K

5.1K

Ticker OSUR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 72,619,104
Market Cap $285M
Description
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.